Home > Healthcare > Autotransfusion Devices Market
Autotransfusion Devices Market Size
- Report ID: GMI8266
- Published Date: Feb 2024
- Report Format: PDF
Autotransfusion Devices Market Size
Autotransfusion Devices Market size was valued at around USD 514.6 million in 2023 and is anticipated to register a CAGR of 6.2% between 2024 and 2032. This robust market growth can be attributed to various factors, including ongoing advancements in technology, surging need for point-of-care testing (POCT) technologies, increasing demand for complex surgical procedures, growing demand for minimally invasive surgical techniques, and the continual growth of healthcare expenditure, among other contributing factors.
Moreover, the global growing trend toward an aging population highlights the importance to address age-related health issues such as anaemia, coagulopathy, and surgical bleeding risk. Autotransfusion devices provide a customized strategy to blood management in the elderly, improving perioperative care and lowering the burden of transfusion-related problems in this vulnerable group.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Autotransfusion Devices Market Size in 2023: | USD 514.6 Million |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 6.2% |
| 2032 Value Projection: | USD 910.1 Million |
| Historical Data for: | 2018 – 2023 |
| No. of Pages: | 110 |
| Tables, Charts & Figures: | 241 |
| Segments covered: | Product, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
For instance, according to a recent United Nations (UN) research, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population.
Furthermore, an increasing demand for sophisticated surgical operations such as cardiovascular surgery, organ transplantation, and oncology requires the growth of suitable blood management systems. Autotransfusion systems assist in controlling intraoperative blood loss and hemostasis in difficult surgical situations, improving surgical results and patient recovery, thereby contributing to the market growth.
Autotransfusion devices are medical instruments designed to collect, process, and reinfuse a patient's own blood during surgical procedures or following significant blood loss. These devices facilitate the recovery and reuse of the patient's own blood, minimizing the need for allogeneic (donor) blood transfusions and reducing the risk of transfusion-related complications.
Frequently Asked Questions (FAQ) :
Autotransfusion Devices Market Scope
